Global T-Cell Therapy Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 CAR T Cell Therapy
  • 1.2.3 TCR Therapy
  • 1.2.4 TIL Therapy
• 1.3 Market by Application
  • 1.3.1 Global T-Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Clinics & Ambulatory Centers
  • 1.3.4 Cancer Research Institutes
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global T-Cell Therapy Market Perspective (2016-2027)
• 2.2 T-Cell Therapy Growth Trends by Regions
  • 2.2.1 T-Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 T-Cell Therapy Historic Market Share by Regions (2016-2021)
  • 2.2.3 T-Cell Therapy Forecasted Market Size by Regions (2022-2027)
• 2.3 T-Cell Therapy Industry Dynamic
  • 2.3.1 T-Cell Therapy Market Trends
  • 2.3.2 T-Cell Therapy Market Drivers
  • 2.3.3 T-Cell Therapy Market Challenges
  • 2.3.4 T-Cell Therapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top T-Cell Therapy Players by Revenue
  • 3.1.1 Global Top T-Cell Therapy Players by Revenue (2016-2021)
  • 3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2016-2021)
• 3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by T-Cell Therapy Revenue
• 3.4 Global T-Cell Therapy Market Concentration Ratio
  • 3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2020
• 3.5 T-Cell Therapy Key Players Head office and Area Served
• 3.6 Key Players T-Cell Therapy Product Solution and Service
• 3.7 Date of Enter into T-Cell Therapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Therapy Breakdown Data by Type

• 4.1 Global T-Cell Therapy Historic Market Size by Type (2016-2021)
• 4.2 Global T-Cell Therapy Forecasted Market Size by Type (2022-2027)

5 T-Cell Therapy Breakdown Data by Application

• 5.1 Global T-Cell Therapy Historic Market Size by Application (2016-2021)
• 5.2 Global T-Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America T-Cell Therapy Market Size (2016-2027)
• 6.2 North America T-Cell Therapy Market Size by Type
  • 6.2.1 North America T-Cell Therapy Market Size by Type (2016-2021)
  • 6.2.2 North America T-Cell Therapy Market Size by Type (2022-2027)
  • 6.2.3 North America T-Cell Therapy Market Size by Type (2016-2027)
• 6.3 North America T-Cell Therapy Market Size by Application
  • 6.3.1 North America T-Cell Therapy Market Size by Application (2016-2021)
  • 6.3.2 North America T-Cell Therapy Market Size by Application (2022-2027)
  • 6.3.3 North America T-Cell Therapy Market Size by Application (2016-2027)
• 6.4 North America T-Cell Therapy Market Size by Country
  • 6.4.1 North America T-Cell Therapy Market Size by Country (2016-2021)
  • 6.4.2 North America T-Cell Therapy Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe T-Cell Therapy Market Size (2016-2027)
• 7.2 Europe T-Cell Therapy Market Size by Type
  • 7.2.1 Europe T-Cell Therapy Market Size by Type (2016-2021)
  • 7.2.2 Europe T-Cell Therapy Market Size by Type (2022-2027)
  • 7.2.3 Europe T-Cell Therapy Market Size by Type (2016-2027)
• 7.3 Europe T-Cell Therapy Market Size by Application
  • 7.3.1 Europe T-Cell Therapy Market Size by Application (2016-2021)
  • 7.3.2 Europe T-Cell Therapy Market Size by Application (2022-2027)
  • 7.3.3 Europe T-Cell Therapy Market Size by Application (2016-2027)
• 7.4 Europe T-Cell Therapy Market Size by Country
  • 7.4.1 Europe T-Cell Therapy Market Size by Country (2016-2021)
  • 7.4.2 Europe T-Cell Therapy Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific T-Cell Therapy Market Size (2016-2027)
• 8.2 Asia-Pacific T-Cell Therapy Market Size by Type
  • 8.2.1 Asia-Pacific T-Cell Therapy Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific T-Cell Therapy Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific T-Cell Therapy Market Size by Type (2016-2027)
• 8.3 Asia-Pacific T-Cell Therapy Market Size by Application
  • 8.3.1 Asia-Pacific T-Cell Therapy Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific T-Cell Therapy Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific T-Cell Therapy Market Size by Application (2016-2027)
• 8.4 Asia-Pacific T-Cell Therapy Market Size by Region
  • 8.4.1 Asia-Pacific T-Cell Therapy Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific T-Cell Therapy Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America T-Cell Therapy Market Size (2016-2027)
• 9.2 Latin America T-Cell Therapy Market Size by Type
  • 9.2.1 Latin America T-Cell Therapy Market Size by Type (2016-2021)
  • 9.2.2 Latin America T-Cell Therapy Market Size by Type (2022-2027)
  • 9.2.3 Latin America T-Cell Therapy Market Size by Type (2016-2027)
• 9.3 Latin America T-Cell Therapy Market Size by Application
  • 9.3.1 Latin America T-Cell Therapy Market Size by Application (2016-2021)
  • 9.3.2 Latin America T-Cell Therapy Market Size by Application (2022-2027)
  • 9.3.3 Latin America T-Cell Therapy Market Size by Application (2016-2027)
• 9.4 Latin America T-Cell Therapy Market Size by Country
  • 9.4.1 Latin America T-Cell Therapy Market Size by Country (2016-2021)
  • 9.4.2 Latin America T-Cell Therapy Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa T-Cell Therapy Market Size (2016-2027)
• 10.2 Middle East & Africa T-Cell Therapy Market Size by Type
  • 10.2.1 Middle East & Africa T-Cell Therapy Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa T-Cell Therapy Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa T-Cell Therapy Market Size by Type (2016-2027)
• 10.3 Middle East & Africa T-Cell Therapy Market Size by Application
  • 10.3.1 Middle East & Africa T-Cell Therapy Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa T-Cell Therapy Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa T-Cell Therapy Market Size by Application (2016-2027)
• 10.4 Middle East & Africa T-Cell Therapy Market Size by Country
  • 10.4.1 Middle East & Africa T-Cell Therapy Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa T-Cell Therapy Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Gilead Sciences, Inc.
  • 11.1.1 Gilead Sciences, Inc. Company Details
  • 11.1.2 Gilead Sciences, Inc. Business Overview
  • 11.1.3 Gilead Sciences, Inc. T-Cell Therapy Introduction
  • 11.1.4 Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2016-2021)
  • 11.1.5 Gilead Sciences, Inc. Recent Development
• 11.2 Sorrento Therapeutics
  • 11.2.1 Sorrento Therapeutics Company Details
  • 11.2.2 Sorrento Therapeutics Business Overview
  • 11.2.3 Sorrento Therapeutics T-Cell Therapy Introduction
  • 11.2.4 Sorrento Therapeutics Revenue in T-Cell Therapy Business (2016-2021)
  • 11.2.5 Sorrento Therapeutics Recent Development
• 11.3 Fate Therapeutics Inc.
  • 11.3.1 Fate Therapeutics Inc. Company Details
  • 11.3.2 Fate Therapeutics Inc. Business Overview
  • 11.3.3 Fate Therapeutics Inc. T-Cell Therapy Introduction
  • 11.3.4 Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2016-2021)
  • 11.3.5 Fate Therapeutics Inc. Recent Development
• 11.4 Novartis International AG
  • 11.4.1 Novartis International AG Company Details
  • 11.4.2 Novartis International AG Business Overview
  • 11.4.3 Novartis International AG T-Cell Therapy Introduction
  • 11.4.4 Novartis International AG Revenue in T-Cell Therapy Business (2016-2021)
  • 11.4.5 Novartis International AG Recent Development
• 11.5 AbbVie Inc.
  • 11.5.1 AbbVie Inc. Company Details
  • 11.5.2 AbbVie Inc. Business Overview
  • 11.5.3 AbbVie Inc. T-Cell Therapy Introduction
  • 11.5.4 AbbVie Inc. Revenue in T-Cell Therapy Business (2016-2021)
  • 11.5.5 AbbVie Inc. Recent Development
• 11.6 Adaptimmune Therapeutics PLC
  • 11.6.1 Adaptimmune Therapeutics PLC Company Details
  • 11.6.2 Adaptimmune Therapeutics PLC Business Overview
  • 11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Introduction
  • 11.6.4 Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2016-2021)
  • 11.6.5 Adaptimmune Therapeutics PLC Recent Development
• 11.7 Bluebird Bio
  • 11.7.1 Bluebird Bio Company Details
  • 11.7.2 Bluebird Bio Business Overview
  • 11.7.3 Bluebird Bio T-Cell Therapy Introduction
  • 11.7.4 Bluebird Bio Revenue in T-Cell Therapy Business (2016-2021)
  • 11.7.5 Bluebird Bio Recent Development
• 11.8 TCR2 Therapeutics, Inc.
  • 11.8.1 TCR2 Therapeutics, Inc. Company Details
  • 11.8.2 TCR2 Therapeutics, Inc. Business Overview
  • 11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Introduction
  • 11.8.4 TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2016-2021)
  • 11.8.5 TCR2 Therapeutics, Inc. Recent Development
• 11.9 Pfizer Inc.
  • 11.9.1 Pfizer Inc. Company Details
  • 11.9.2 Pfizer Inc. Business Overview
  • 11.9.3 Pfizer Inc. T-Cell Therapy Introduction
  • 11.9.4 Pfizer Inc. Revenue in T-Cell Therapy Business (2016-2021)
  • 11.9.5 Pfizer Inc. Recent Development
• 11.10 DiaCarta, Inc.
  • 11.10.1 DiaCarta, Inc. Company Details
  • 11.10.2 DiaCarta, Inc. Business Overview
  • 11.10.3 DiaCarta, Inc. T-Cell Therapy Introduction
  • 11.10.4 DiaCarta, Inc. Revenue in T-Cell Therapy Business (2016-2021)
  • 11.10.5 DiaCarta, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer